Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Leuvectin MeSH Supplementary Concept Data 2025


MeSH Supplementary
Leuvectin
Unique ID
C494381
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C494381
Registry Numbers
0
Heading Mapped to
*Cancer Vaccines
Frequency
1
Note
Leuvectin (Vical Inc., San Diego, CA) is a gene transfer product in which a plasmid encoding the human interleukin-2 (IL-2) gene is complexed with the cationic lipid 1,2-dimyristyloxypropyl-3-dimethylhydroxyethyl ammonium bromide/dioleoylphosphatidylethanolamine (DMRIE/DOPE); vaccination in patients with metastatic renal cell carcinoma is claimed to be safe & well tolerated
Source
Cancer 2004 Dec 1;101(11):2557-66
Indexing Information
Gene Transfer Techniques
Date of Entry
2004/12/23
Revision Date
2004/12/23
Leuvectin Preferred
page delivered in 0.007s